724 related articles for article (PubMed ID: 16708455)
21. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
Dale SB; Verdier JM
Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
[No Abstract] [Full Text] [Related]
22. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
23. Drug card setback highlights need for cost relief.
Gundling RL
Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
[TBL] [Abstract][Full Text] [Related]
24. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
Fischer MA; Avorn J
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-19. PubMed ID: 20213917
[No Abstract] [Full Text] [Related]
26. Medicaid: Medicaid: benefits and services--2005. End of Year Issue Brief.
Johnson P
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16708442
[TBL] [Abstract][Full Text] [Related]
27. Medicaid: Medicaid: waivers--2005. End of Year Issue Brief.
Johnson P
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710918
[TBL] [Abstract][Full Text] [Related]
28. Medicaid and indigent care issue brief: Medicaid: benefits and services: year end report-2003.
Johnson P
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-33. PubMed ID: 14969254
[TBL] [Abstract][Full Text] [Related]
29. Medicaid cost containment and access to prescription drugs.
Cunningham PJ
Health Aff (Millwood); 2005; 24(3):780-9. PubMed ID: 15886173
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceuticals: Medicaid drug cost containment: year end report-2002.
Floridi T; Kammer C
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-13. PubMed ID: 12856684
[No Abstract] [Full Text] [Related]
31. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
32. Trends in prescription drug expenditures by Medicaid enrollees.
Banthin JS; Miller GE
Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
[TBL] [Abstract][Full Text] [Related]
33. Molecular medicine, the Medicare drug benefit, and the need for cost control.
Gillick MR
J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
[TBL] [Abstract][Full Text] [Related]
34. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
[TBL] [Abstract][Full Text] [Related]
35. Medicaid: Medicaid: provider reimbursement--2005. End of Year Issue Brief.
Johnson P
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-11. PubMed ID: 16710912
[TBL] [Abstract][Full Text] [Related]
36. Medicaid preferred drug lists' costs to physicians.
Ketcham JD; Epstein AJ
Med Care; 2008 Jan; 46(1):9-16. PubMed ID: 18162850
[TBL] [Abstract][Full Text] [Related]
37. Consumers face higher costs as health plans seek to control drug spending.
Mays GP; Hurley RE; Grossman JM
Issue Brief Cent Stud Health Syst Change; 2001 Nov; (45):1-4. PubMed ID: 11865903
[TBL] [Abstract][Full Text] [Related]
38. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
39. Three years of state fiscal struggles: how did Medicaid and SCHIP fare?
Coughlin TA; Zuckerman S
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-385-98. PubMed ID: 16105853
[TBL] [Abstract][Full Text] [Related]
40. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
